TELA Bio, Inc.
TELA- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001561921
In the last 90 days, TELA Bio, Inc. insiders filed 4 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $19.3M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in TELA Bio, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +2 vs. Q1 2022
- Shares held
- 13.5M
- +2.37M (+21.3%) vs. Q1 2022
- Total value
- $95.0M
- −$34.8M (−26.8%) vs. Q1 2022
- New holders
- 8
- 11 more added
- Sold out
- 6
- 6 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TELA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $19.3M |
| Q1 2026 | 36 | $16.7M |
| Q4 2025 | 42 | $32.5M |
| Q3 2025 | 40 | $35.1M |
| Q2 2025 | 46 | $45.5M |
| Q1 2025 | 50 | $30.0M |
| Q4 2024 | 47 | $81.6M |
| Q3 2024 | 49 | $45.6M |
| Q2 2024 | 68 | $93.4M |
| Q1 2024 | 59 | $120.6M |
| Q4 2023 | 61 | $142.7M |
| Q3 2023 | 68 | $178.1M |
| Q2 2023 | 68 | $227.2M |
| Q1 2023 | 54 | $180.2M |
| Q4 2022 | 49 | $200.4M |
| Q3 2022 | 45 | $143.0M |
| Q2 2022 | 32 | $95.0M |
| Q1 2022 | 30 | $129.8M |
| Q4 2021 | 36 | $134.8M |
| Q3 2021 | 38 | $139.8M |
| Q2 2021 | 45 | $164.9M |
| Q1 2021 | 47 | $147.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding TELA Bio, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 47 | $0 | 0.00% | +4+9.3% | Added |
| Sterling Investment Advisors, Ltd. | 834 | $6.00K | 0.00% | +834 | New |
| Royal Bank of Canada | 1,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,085 | $15.0K | 0.00% | +953+84.2% | Added |
| Tower Research Capital LLC (TRC) | 10,521 | $74.0K | 0.00% | +9,331+784.1% | Added |
| Renaissance Technologies LLC | 11,900 | $83.0K | 0.00% | +11,900 | New |
| Northern Trust Corp | 13,994 | $98.0K | 0.00% | −918−6.2% | Reduced |
| BlackRock Inc. | 14,625 | $103.0K | 0.00% | −6,798−31.7% | Reduced |
| State Street Corp | 26,065 | $185.0K | 0.00% | 00.0% | Unchanged |
| WMS Partners, LLC | 28,150 | $197.0K | 0.03% | 00.0% | Unchanged |
| Millennium Management LLC | 38,263 | $272.0K | 0.00% | +38,263 | New |
| The PNC Financial Services Group, Inc. | 53,612 | $376.0K | 0.00% | +6,433+13.6% | Added |
| Geode Capital Management, LLC | 68,369 | $486.0K | 0.00% | +3,447+5.3% | Added |
| Bridgeway Capital Management, LLC | 77,000 | $547.0K | 0.01% | +15,000+24.2% | Added |
| Sanders Morris Harris LLC | 96,168 | $674.0K | 0.15% | −9,000−8.6% | Reduced |
| Parkman Healthcare Partners LLC | 108,984 | $764.0K | 0.28% | +480+0.4% | Added |
| Jacob Asset Management of New York LLC | 116,095 | $825.0K | 0.83% | −12,899−10.0% | Reduced |
| Worth Venture Partners, LLC | 113,012 | $904.0K | 0.55% | +113,012 | New |
| Schonfeld Strategic Advisors LLC | 140,372 | $984.0K | 0.01% | −5,364−3.7% | Reduced |
| Jefferies Group LLC | 145,507 | $1.02M | 0.03% | +145,507 | New |
| Granite Point Capital Management, L.P. | 227,644 | $1.60M | 1.39% | 00.0% | Unchanged |
| Hamilton Lane Advisors LLC | 264,366 | $1.85M | 0.72% | +264,366 | New |
| AIGH Capital Management LLC | 306,464 | $2.16M | 0.90% | +306,464 | New |
| Pentwater Capital Management LP | 390,000 | $2.73M | 0.05% | +77,762+24.9% | Added |
| Vanguard Group Inc | 391,568 | $2.75M | 0.00% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 498,238 | $3.49M | 3.70% | +46,838+10.4% | Added |
| Pura Vida Investments, LLC | 555,623 | $3.90M | 0.62% | −11,797−2.1% | Reduced |
| Industry Ventures, L.L.C. | 579,745 | $4.06M | 4.31% | +579,745 | New |
| RTW Investments, LP | 1,017,546 | $7.13M | 0.18% | 00.0% | Unchanged |
| Opaleye Management Inc. | 1,643,367 | $11.5M | 5.19% | +1,166,367+244.5% | Added |
| OrbiMed Advisors LLC | 3,027,542 | $21.2M | 0.41% | 00.0% | Unchanged |
| Essex Woodlands Management, Inc. | 3,565,709 | $25.0M | 10.33% | +249,473+7.5% | Added |
| Silvercrest Asset Management Group LLC | 0 | $0 | 0.00% | −396,585−100.0% | Sold out |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −192,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,380−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −10,548−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −171−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −206−100.0% | Sold out |